Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.14
09.01.22
-
09.01.23
-5.80%
23.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
buy
Biocept Inc.

Start price
Target price
Perf. (%)
€147.00
21.01.21
€3,000.0
21.01.22
-48.16%
22.01.22

Could be very worthwhile Investment >20% year
buy
Thermogenesis Holdings Inc.

Start price
Target price
Perf. (%)
€88.65
11.01.21
-
11.01.22
-53.05%
12.01.22

buy
Eckert-Ziegler Bg

Start price
Target price
Perf. (%)
-
09.09.21
€140.00
-
10.01.22

buy
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€30.00
04.10.21
-
04.10.22
-39.47%
10.01.22

Could be worthwhile Investment >10% per year
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
buy
Avacta Group plc

Start price
Target price
Perf. (%)
€1.41
25.12.21
€2.00
25.12.22
-30.50%
08.01.22

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€18.75
05.01.21
€25.00
05.01.22
-38.87%
06.01.22

buy
Fulgent Genetics Inc

Start price
Target price
Perf. (%)
€58.02
17.05.21
€89.00
17.05.22
31.20%
05.01.22

buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.40
15.12.20
€3.00
15.12.21
-10.00%
16.12.21

buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€7.40
26.11.21
-
26.11.22
-40.27%
14.12.21

buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€6.40
26.11.21
-
26.11.22
14.84%
28.11.21

Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.80
05.11.21
-
05.11.22
-22.00%
14.11.21

buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€13.60
08.11.21
-
08.11.22
0.00%
13.11.21

buy
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.19
05.10.21
-
05.10.22
41.25%
05.11.21

Could be worthwhile Investment >10% per year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.58
15.01.21
€4.00
15.01.22
54.89%
05.11.21

Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€9.75
01.11.20
-
04.11.21
26.15%
05.11.21

buy
Nipro Corp

Start price
Target price
Perf. (%)
€9.60
02.10.20
€12.00
04.11.21
-8.85%
05.11.21

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.80
22.09.20
-
04.11.21
-49.18%
05.11.21

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group